Format

Send to

Choose Destination
PLoS One. 2013 Dec 16;8(12):e82325. doi: 10.1371/journal.pone.0082325. eCollection 2013.

Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.

Author information

1
Department of Neurology, Seoul National University, College of Medicine, Seoul, Korea.
2
Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.
3
Department of Neurology, Seoul National University, Bundang Hospital, Gyeonggi, Korea.
4
Department of Neurology, Seoul National University, College of Medicine, Seoul, Korea ; Department of Neurology, Seoul National University, Bundang Hospital, Gyeonggi, Korea.

Abstract

BACKGROUND AND OBJECTIVE:

Neuromyelitis optica (NMO) is an inflammatory demyelinating disorder of the central nervous system with a relapsing and remitting course. We aimed to identify factors associated with the time to next attack, including the effect of the natural disease course and the diverse treatment regimens, by applying a longitudinal statistical analysis to the individual attacks of each patient.

METHODS:

In total, 184 acute attacks among 58 patients with either NMO or NMO spectrum disorder with anti-aquaporin-4 antibody were assessed retrospectively. Patient demographics, clinical characteristics at each attack, and type of treatment during inter-attack periods were assessed. The dependent variable was defined as the time from each attack to the next attack (inter-attack interval). An exponential accelerated failure time model with shared gamma frailty was adapted for statistical analysis.

RESULTS:

A multivariable analysis revealed that the time from each attack to the next attack in NMO increased independently by 1.31 times (95% confidence interval (CI), 1.02-1.67; p = 0.035) with each additional cumulative attack experienced, by 5.34 times (95% CI, 1.57-18.13; p = 0.007) with combined azathioprine treatment and continued oral prednisolone, and by 4.26 times (95% CI, 1.09-16.61; p = 0.037) with rituximab treatment.

CONCLUSION:

The time to next attack in NMO can increase naturally in the later stages of the disease as the number of cumulative attacks increases. Nevertheless, both combined azathioprine treatment with continued oral prednisolone and rituximab treatment were also associated with a longer time to next attack, independently of the natural disease course of NMO.

PMID:
24358171
PMCID:
PMC3864949
DOI:
10.1371/journal.pone.0082325
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center